Navigation Links
Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
Date:2/5/2008

TF(TM)), designed to upregulate the vascular

endothelial growth factor-A (VEGF-A) gene.

-- Initiation of additional Phase 2 clinical trials of SB-509 in moderate

to severe DN (SB-509-701) and stem cell mobilization (SB-509-703). In

April, Sangamo announced the initiation of a randomized, single-blind,

placebo-controlled, repeat-dosing Phase 2 study designed to evaluate

the clinical safety and effects of repeat administration of SB-509 in

subjects that have moderate to severe DN (SB-509-701). In January

2008, Sangamo announced that it had initiated a randomized,

single-blind, placebo-controlled, multi-center Phase 2 clinical trial

(SB-509-703) in subjects with mild to moderate DN designed to evaluate

the pharmacokinetics of stem cell mobilization into the bloodstream

after treatment with varying doses of SB-509 as well as the clinical

safety and clinical effects of SB-509 administration.

-- Completion of enrollment of Phase 2 clinical trial of SB-509 for mild

to moderate DN (SB-509-601). In December, Sangamo announced that

enrollment was complete in a randomized, double-blind, repeat-dosing,

placebo-controlled, multi-center trial to evaluate SB-509 for the

treatment of mild to moderate DN. The company expects to have data

from this trial in the second half of 2008.

-- Establishment of major alliance with Sigma-Aldrich Corporation. In

July, as part of an agreement to develop and commercialize high value

laboratory research reagents based upon Sangamo's ZFP technology,

Sangamo received an upfront payment of $13.5 million which included

license fees and the purchase of one million shares of Sangamo stock.

Sangamo is also eligible to receive research funding, development and

commercial milestone payments of up to $24 m
'/>"/>

SOURCE Sangamo BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Sangamo BioSciences Announces Completion of Enrollment of Phase 2 Clinical Trial of ZFP Therapeutic for Diabetic Neuropathy
2. Sangamo BioSciences and Sigma-Aldrich Announce Nature Biotechnology Study Demonstrating Zinc Finger Technology for Modification of Human Stem Cells
3. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2007 Results
4. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
5. CeloNova BioSciences Announces Positive Results from European Study of Embozene(TM) Microspheres for Treatment of Uterine Fibroids
6. Epiphany Biosciences Reports Initiation of Phase 2 Study of Valomaciclovir for the Treatment of Acute Infectious Mononucleosis
7. Ardea Biosciences, Inc. Announces New Clinical Development Program Directed Toward the Treatment of Gout
8. Epiphany Biosciences Reports Initiation and Enrollment in Valomaciclovir Study for Shingles
9. Regado Biosciences Presents Early Stage Clinical Data for REG1 Anticoagulation System at American Heart Association 2007 Scientific Sessions
10. Regado Biosciences Presents Positive Data From REG1 Anticoagulation System Phase Ic Study at American Heart Association 2007 Scientific Sessions
11. Regado Biosciences Initiates Phase IIa Clinical Study of REG1 Anticoagulation System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... , Aug. 22, 2014  WaferGen Bio-systems, Inc. (NASDAQ: ... offering of units of common stock and warrants at ... of $20 million, prior to deducting underwriting discounts and ... shares and warrants are immediately separable and will be ... to begin trading on The NASDAQ Stock Market under ...
(Date:8/21/2014)... Hermann Health System and The University of Texas ... to provide a new level of specialized breast screening at ... Houston area. Starting in ... professional breast radiology services for five of Memorial Hermann,s 10 ... Woodlands , Northeast, Southwest and Sugar Land ...
(Date:8/21/2014)... Nektar Therapeutics (NASDAQ: NKTR ... results from its Phase 3 pivotal clinical trial ... factor VIII (rFVIII) treatment for hemophilia A based ... primary endpoint in reducing annualized bleed rates (ABR) ... arm. Top-line results from the prospective, ...
Breaking Medicine Technology:WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 2WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 3WaferGen Bio-Systems Announces Pricing of $20 Million Underwritten Offering and Uplisting to NASDAQ 4Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 2Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 3Memorial Hermann, MD Anderson join forces to provide enhanced breast imaging services throughout the Greater Houston Region 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 2Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 3Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 4Baxter Announces Positive Top-Line Results from Its Phase 3 Study of BAX 855, Extended Half-Life Recombinant FVIII for Hemophilia A Patients 5
(Date:8/23/2014)... 2014 Dealing with a drug or alcohol ... the addict is a child. Adolescent addiction has been an ... time, but a new helpline is now providing a valuable ... to find a real addiction recovery center. , The Troubled ... impact in the community. By calling (404) 975-2762, parents and ...
(Date:8/23/2014)... 2014 Teen drug and alcohol abuse ... different in Wilmington, NC. Substance abuse can happen to ... to drug and alcohol dependency in higher numbers than ... overcome substance abuse, but don’t know where to find ... can be a challenge because most treatment options are ...
(Date:8/23/2014)... Summer vacation is almost over and before we know ... shopping for school supplies and a new wardrobe might take ... students to also spend some time brushing up on bed ... thrive in heavily populated places,” said Randy Rupert, Bed Bug ... perfect settings for bed bugs to take up residence.” , ...
(Date:8/22/2014)... The IT manager of Top10BestSEOHosting.com is a ... years. He has recently announced that GoDaddy ( http://www.top10bestseohosting.com/go/GoDaddy.com/ ... 2014. , GoDaddy is a popular supplier of cheap ... hosting solutions at affordable rates. It offers three Linux ... plans depend on the length of the contract. The ...
(Date:8/22/2014)... On Friday, Aug. 22, Liberty University ... Sciences , hosting a ceremony in its courtyard attended ... and public welfare. , The 162-member inaugural class of ... (LUCOM) joined Liberty staff, faculty, and community leaders in ... new medical school. Classes began on Monday, Aug. 4. ...
Breaking Medicine News(10 mins):Health News:Atlanta’s New Troubled Teen Helpline Is Making a Difference in the Community 2Health News:Troubled Teens Wilmington Helpline Guides Adolescents to the Path of Recovery 2Health News:Expert Advice for a Bed Bug-Free School Year 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 2Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 3Health News:Liberty University Dedicates Its New Center for Medical and Health Sciences 4
... it still hasn,t been determined whether one disorder causes ... (HealthDay News) -- Alcohol abuse may increase the risk ... New Zealand study suggests. , Previous research has identified ... depression. But it hasn,t been determined whether one disorder ...
... Calif., March 6 Huntington Hospital Cancer Center ... the American College of Surgeons Commission on Cancer ... excellence in providing quality care to their patients."This ... commitment by Huntington,s medical staff, hospital staff and ...
... knees less effective in deep joint areas, study finds ... injection of hyaluronic acid is no more effective than a ... finds. , Hyaluronic acid (HA), a substance found in normal ... fluid, which lubricates and protects joints. The use of HA ...
... 6 /PRNewswire-Asia-FirstCall/ -- China Yingxia,International, Inc. (OTC ... a leading provider in the nutraceutical industry ... nutritional food products,dietary supplements and personal care ... today disclosed that its CEO and chairwoman, ...
... chest wall to decrease volume, study says , , FRIDAY, ... middle can put the squeeze on your lungs, according ... , It was already known that abdominal obesity (waist ... than 40 inches for men) was associated with diabetes, ...
... 6 The Penta Water Company ( http://pentawater.com ), ... water, is taking the bold step of turning to ... for their new packaging.In collaboration with Earth First Packaging ... the bottle water industry to convert its plastic-based BOPP ...
Cached Medicine News:Health News:Drinking May Trigger Genetic Marker for Depression 2Health News:Huntington Hospital Cancer Center Receives Outstanding Achievement Designation 2Health News:Hip Osteoarthritis Therapy No Better Than Placebo 2Health News:China Yingxia International, Inc.'s chairwoman and CEO is in talks with investors in China 2Health News:China Yingxia International, Inc.'s chairwoman and CEO is in talks with investors in China 3Health News:Belly Fat Puts the Pressure on Lungs 2Health News:Back to Basics: Penta Water Pairs Its Ultra-Pure Water With Packaging Made of Rock 2
Autolensmeter with color 5.7 inch LCD screen and built in printer....
... CF-60UVi is a diversified wide-angle ... FAG, ICG (optional) with various ... in the market), 40 degrees ... one picture and 30 degrees ...
... to eliminate the subjective nature of manual ... repeatable, objective measurements every time. The easy ... operating system ensure fast and simple operation. ... lens positioning and, in auto mode, users ...
An ideal basic fundus fluorescein camera with quality enhancing features at a mid-range price point. The camera has 1.7x magnification at 60 degree and 2.5x at 40 degree....
Medicine Products: